Nicole Doria-Rose, PhD

Chief, Humoral Immunology Core at Vaccine Researchy Center

Dr. Nicole Doria-Rose is an expert in identification and characterization of broadly neutralizing antibodies from HIV-infected patients, with an emphasis on patients followed from the time of infection. She discovered and developed a high-throughput method for culturing and screening single B cells for antibody discovery, and isolated the most potently HIV-neutralizing antibody yet known. As Chief of the Humoral Immunology Core at the Vaccine Research Center, National Institutes of Health, USA, she leads a program that evaluates the immune responses to novel HIV and COVID-19 immunogens, and investigates the clinical use of broadly neutralizing antibodies for prevention of HIV-1.